A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

Authors: Pujol, Jean-Louis, Greillier, Laurent, Audigier-Valette, Clarisse, Moro-Sibilot, Denis, Uwer, Lionel, Hureaux, José, Guisier, Florian, Carmier, Delphine, Madelaine, Jeannick, Otto, Josiane, Gounant, Valérie, Merle, Patrick, Mourlanette, Pierre, Molinier, Olivier, Renault, Aldo, Rabeau, Audrey, Antoine, Martine, Denis, Marc G., Bommart, Sebastien, Langlais, Alexandra, Morin, Franck, Souquet, Pierre-Jean

Source: In Journal of Thoracic Oncology May 2019 14(5):903-913

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

Authors: DEBIEUVRE, Didier, HIRET, Sandrine, CADRANEL, Jacques, FRABOULET-MOREAU, Séverine, CARMIER, Delphine, Scherpereel, Arnaud, Mazieres, Julien, Greillier, Laurent, Lantuejoul, Sylvie, Dô, Pascal, Bylicki, Olivier, Monnet, Isabelle, Corre, Romain, Audigier-Valette, Clarisse, Locatelli-Sanchez, Myriam, Molinier, Olivier, Guisier, Florian, Urban, Thierry, Ligeza-Poisson, Catherine, Planchard, David, Amour, Elodie, Morin, Franck, Moro-Sibilot, Denis, Zalcman, Gérard

Source: In The Lancet Oncology February 2019 20(2):239-253

Linear Cutaneous Erythema in a Patient With Amyotrophic Lateral Sclerosis

Authors: De Kyvon, Marie-Alix, Drillaud, Nicolas, Henique, Helène, Carmier, Delphine, Beltran, Stéphane, Corcia, Philippe, Bernard, Louis, Chandenier, Brigitte, Chandenier, Jacques, Desoubeaux, Guillaume

Source: Clinical Infectious Diseases, 2018 May . 66(10), 1637-1638.

Access URL: https://www.jstor.org/stable/26526145

Cross-Cultural Adaptation and Psychometric Validation of the French Version of the FAMCARE-Patient (FFP-16) Questionnaire for Outpatients With Advanced-Stage Cancer

Authors: Chaumier, François, Flament, Thomas, Lecomte, Thierry, Vegas, Hélène, Stacoffe, Marion, Pichon, Eric, Narciso, Bérangère, Caulet, Morgane, Barbe, Catherine, Jaillais, Anaïs, Carmier, Delphine, By, Marie-Agnès, Bourdon, Marianne, Hardouin, Jean-Benoît

Source: JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 60(1):94-100.e1

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100115815613.0x000001&indx=1&recIds=ETOCvdc_100115815613.0x000001

EGFR -Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?

Authors: Cansouline, Xavier, Lipan, Béatrice, Sizaret, Damien, Tallet, Anne, Vandier, Christophe, Carmier, Delphine, Legras, Antoine

Source: Cancers; May2022, Vol. 14 Issue 9, pN.PAG-N.PAG, 14p

Subject Terms: LUNG cancer, ADJUVANT chemotherapy, GENETIC mutation, EPIDERMAL growth factor receptors, PROTEIN-tyrosine kinase inhibitors, TUMOR classification, SURVIVAL analysis (Biometry), COST effectiveness, PROGRESSION-free survival

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

IV Immunoglobulin Might Be Considered as a First-line Treatment of Severe Interstitial Lung Disease Associated With Polymyositis

Authors: Diot, Elisabeth, Carmier, Delphine, Marquette, David, Marchand-Adam, Sylvain, Diot, Patrice, Lesire, Vincent

Source: In Chest August 2011 140(2):562-563

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.

Authors: Herbreteau, Guillaume, Langlais, Alexandra, Greillier, Laurent, Audigier-Valette, Clarisse, Uwer, Lionel, Hureaux, José, Moro-Sibilot, Denis, Guisier, Florian, Carmier, Delphine, Madelaine, Jeannick, Otto, Josiane, Souquet, Pierre-Jean, Gounant, Valérie, Merle, Patrick, Molinier, Olivier, Renault, Aldo, Rabeau, Audrey, Morin, Franck, Denis, Marc G, Pujol, Jean-Louis

Source: Journal of Clinical Medicine; Dec2020, Vol. 9 Issue 12, p3861, 1p

Subject Terms: CIRCULATING tumor DNA, SMALL cell lung cancer, PROGRESSION-free survival, CANCER patients

This result is not displayed to guests.
Login for full access.